A group of the world’s leading drugmakers have joined the U.K.’s ambitious initiative to sequence the genomes of 100,000 Britons, mining the data with hopes of finding new pathways to treat cancer and rare diseases.

…read more

Source: Big Pharma joins the U.K.’s genomics project with eyes on drug discovery


0 No comments